{"nctId":"NCT00975507","briefTitle":"ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)","startDateStruct":{"date":"1998-03"},"conditions":["Measles","Mumps","Rubella","Varicella"],"count":480,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live","Biological: Comparator: Placebo"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Comparator: Varivax","Biological: Comparator: M-M-R II"]}],"interventions":[{"name":"Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live","otherNames":["ProQuad™"]},{"name":"Comparator: Placebo","otherNames":[]},{"name":"Comparator: Varivax","otherNames":[]},{"name":"Comparator: M-M-R II","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* In good health\n* Negative clinical history of varicella, shingles, measles, mumps, and rubella\n\nExclusion Criteria:\n\n* Previous receipt of measles, mumps, rubella and/or varicella vaccine either alone or in combination\n* Any immune impairment or deficiency\n* Exposure to measles, mumps, rubella, varicella, or zoster in the 4 weeks prior to vaccination\n* Vaccination with an inactive vaccine with in the past 14 days\n* Vaccination with a live vaccine within the past 30 days\n* Immune globulin or any blood product administered in the past 3 months","healthyVolunteers":true,"sex":"ALL","minimumAge":"12 Months","maximumAge":"23 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Postvaccination Varicella Antibody Titer ≥5 Glycoprotein Enzyme-Linked Immunosorbent Assay (gpELISA) Units/mL for Subjects Initially Seronegative (a Titer of <0.6 gpELISA Units/mL) to Varicella at Baseline","description":"Antibody Response to Varicella at 6 Weeks Postvaccination for Subjects Initially Seronegative (a titer of \\<0.6 gpELISA units/mL) to Varicella at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"228","spread":null},{"groupId":"OG001","value":"237","spread":null},{"groupId":"OG002","value":"118","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Postvaccination Measles ELISA Antibody Titer ≥207.8 mIU/mL","description":"Antibody Response to Measles at 6 Weeks Postvaccination for Subjects Initially Seronegative (a titer \\<207.8 mIU/mL) to Measles at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"290","spread":null},{"groupId":"OG001","value":"284","spread":null},{"groupId":"OG002","value":"145","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Postvaccination Varicella Antibody Titer ≥5 gpELISA Units/mL for Subjects Initially With Varicella Antibody Titer <1.25 gpELISA Units/mL at Baseline","description":"Antibody Response to Varicella at 6 Weeks Postvaccination for Subjects Initially With Varicella Antibody Titer \\<1.25 gpELISA units/mL at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"264","spread":null},{"groupId":"OG001","value":"275","spread":null},{"groupId":"OG002","value":"134","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Postvaccination Mumps ELISA Antibody Titer ≥2.0 Ab Units/mL","description":"Antibody Response to Mumps at 6 Weeks Postvaccination for Subjects Initially Seronegative (a titer \\<2.0 Ab Units/mL) to Mumps at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"292","spread":null},{"groupId":"OG001","value":"283","spread":null},{"groupId":"OG002","value":"148","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Postvaccination Rubella ELISA Antibody Titer ≥10 IU/mL","description":"Antibody Response to Rubella at 6 Weeks Postvaccination for Subjects Initially Seronegative (a titer \\<10 IU/mL) to Rubella at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"289","spread":null},{"groupId":"OG001","value":"275","spread":null},{"groupId":"OG002","value":"142","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":321},"commonTop":["Fever","Infection, Respiratory, Upper","Irritability","Diarrhea","Rash"]}}}